The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 1029-1034

  Tabolli, S ^a   Mozzetta, A ^a   Antinone, V ^a   Alfani, S ^a   Cianchini, G ^a   Abeni, D ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Depression; Health status; Pemphigus; SF 36

Indexed keywords

DESMOGLEIN 3 ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANXIETY; ARTICLE; CHRONIC DISEASE; CORRELATION ANALYSIS; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PERSONALITY AND ABILITY TESTING QUESTIONNAIRE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36;

ADULT; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 42049098204     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08481.x     Document Type: Article

References (24)

1. Sitaru C, Zillikens D. Mechanisms of blister induction by autoantibodies. Exp Dermatol 2005 14 : 861 75.
2. Bystryn IC, Rudolph JL. Pemphigus. Lancet 2005 366 : 61 73.
3. Tron F, Gilbert D, Mouquet H et al. Genetic factors in pemphigus. J Autoimmun 2005 24 : 319 28.
4. Salato VK, Hacker-Foegen MK, Lazarova Z et al. Role of intramolecular epitope spreading in pemphigus vulgaris. Clin Immunol 2005 116 : 54 64.
5. Wojnarowska F, Venning VA, Burge SM. Immunobullous diseases. In : Rook's Textbook of Dermatology (Burns T, Breathnach SM, Cox NH, Griffiths CEM, eds 7th edn, Vol. 2. Oxford : Blackwell Publishing, 2004 41.5 41.17.
6. Ikeda S, Imamura S, Hashimoto I et al. History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan. Arch Dermatol Res 2003 295 : S12 16.
7. Harman KE, Albert S, Black MM. British Association of Dermatologists guidelines for the management of pemphigus vulgaris. Br J Dermatol 2003 149 : 926 37.
8. Martin LK, Werth VP, Agero AL et al. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev 2007 3 : 006263.
9. Terrab Z, Benchikhi H, Maaroufi A et al. Quality of life and pemphigus. Ann Dermatol Venereol 2005 132 : 321 8.
10. Mayrshofer F, Hertl M, Stinkraven R et al. Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group. J Dtsch Dermatol Ges 2005 3 : 431 5.
11. Ware JE Jr., Sherbourne CD. The MOS 36-item short form health survey (SF-36). Conceptual framework and item selection. Med Care 1992 30 : 473 83.
12. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998 51 : 1025 36.
13. Krug SE, Scheier IH, Cattel RB. Handbook for the IPAT Anxiety Scale. Champaign, IL : Institute for Personality and Ability Testing, 1976.
14. Krug SE, Laughlin JE. Handbook for the IPAT Depression Scale. Champaign, IL : Institute for Personality and Ability Testing, 1976.
15. Sampogna F, Tabolli S, Söderfeldt B et al. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006 154 : 844 9.
16. Tabolli S, Baliva G, Lombardo GA et al. Health related quality of life assessment in the routine clinical practice of a dermatology unit. Eur J Dermatol 2006 16 : 409 15.
17. Uzun S, Durdu M, Akman A et al. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases. Int J Dermatol 2006 45 : 523 8.
18. Chams-Davatchi C, Valikhani M, Daneshpazhooh M et al. Pemphigus: analysis of 1209 cases. Int J Dermatol 2005 44 : 470 6.
19. Fitzpatrick RE, Newcomer VD. The correlation of disease activity and antibody titers in pemphigus. Arch Dermatol 1980 116 : 285 90.
20. Cheng SW, Kobayashi M, Kinishita-Kuroda K et al. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assays using recombinant desmogleins 1 and 3. Br J Dermatol 2002 147 : 261 5.
21. Harman KE, Seed PT, Gratian MJ et al. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody level. Br J Dermatol 2001 144 : 775 80.
22. Sampogna F, Picardi A, Chren MM et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004 66 : 620 4.
23. Sampogna F, Tabolli S, Abeni D, and the IMPROVE investigators. The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. Br J Dermatol 2007 157 : 508 13.
24. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997 133 : 1433 40.